Evotec (NASDAQ:EVO) Shares Gap Up – Still a Buy?

Evotec SE (NASDAQ:EVO)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $4.44, but opened at $4.58. Evotec shares last traded at $4.45, with a volume of 39,766 shares trading hands.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and set a $8.00 price objective on shares of Evotec in a research note on Thursday, November 7th.

Evotec Price Performance

The business’s 50 day moving average price is $4.40 and its 200-day moving average price is $4.06. The company has a quick ratio of 1.99, a current ratio of 2.09 and a debt-to-equity ratio of 0.43.

Institutional Investors Weigh In On Evotec

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets bought a new position in Evotec during the 4th quarter worth approximately $27,000. CSS LLC IL bought a new stake in Evotec during the 4th quarter worth approximately $50,000. Bank of America Corp DE boosted its holdings in shares of Evotec by 262.5% in the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock valued at $53,000 after buying an additional 9,289 shares during the period. Lighthouse Investment Partners LLC acquired a new stake in shares of Evotec during the fourth quarter worth $166,000. Finally, DCF Advisers LLC lifted its position in Evotec by 5.9% in the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock valued at $956,000 after acquiring an additional 12,816 shares in the last quarter. Institutional investors and hedge funds own 5.81% of the company’s stock.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.